Plasma brain natriuretic peptide levels are elevated in patients with cancer
Sachiko Bando(Tokushima University), Masataka Sata(Tokushima University), Takeshi Tobiume(Tokushima University), Tomomi Matsuura(Keio University), Kenya Kusunose(University of the Ryukyus), Tetsuji Takayama(Tokushima University), Takayuki Ise(Tokushima University Hospital), Daiju Fukuda(Osaka City University), Kenji Kangawa(National Cerebral and Cardiovascular Center), Takeshi Soeki(Tokushima University), Michio Shimabukuro(Fukushima Medical University), Takashi Iwase(ENVIRON (United States)), Koji Yamaguchi(University of Occupational and Environmental Health Japan), Shusuke Yagi(Shikoku Central Hospital of the Mutual Aid Association of Public School Teachers), Hirotsugu Yamada(Tokushima University Hospital), Ichiro Kishimoto(Kyoto University), Tetsuzo Wakatsuki(Tokushima University), Naoki Muguruma(Tokushima University)
Cited by 72
Related Papers
Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
|Cell stem cell|2012|1.1k
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307